Specialty pharmaceutical and medical device company Delcath Systems Inc. (DCTH) said Thursday it plans to offer shares of its common stock and warrants to purchase shares of common stock in an underwritten public offering. Delcath said the offering is subject to market and other conditions.
Delcath said it expects to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the shares of common stock and warrants offered in the public offering to cover over-allotments, if any.
The company expects that the proceeds of the offering will mainly be used for general corporate purposes.
Cowen and Company, LLC and Wedbush PacGrow Life Sciences are acting as joint book-runners for the offering. Roth Capital Partners is acting as co-manager for the offering.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.